Arbutus Biopharma
ABUS
#6525
Rank
HK$5.82 B
Marketcap
HK$30.30
Share price
-5.60%
Change (1 day)
15.81%
Change (1 year)

Market capitalization of Arbutus Biopharma (ABUS)

Market cap: HK$5.82 Billion

As of February 2026 Arbutus Biopharma has a market cap of HK$5.82 Billion. This makes Arbutus Biopharma the world's 6525th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arbutus Biopharma from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$5.82 B-18.53%
2025HK$7.15 B51.47%
2024HK$4.72 B44.22%
2023HK$3.27 B14.95%
2022HK$2.84 B-35.75%
2021HK$4.43 B89.73%
2020HK$2.33 B66.6%
2019HK$1.40 B-18.22%
2018HK$1.71 B-21.05%
2017HK$2.17 B108.5%
2016HK$1.04 B-44.64%
2015HK$1.88 B-28.62%
2014HK$2.63 B123.97%
2013HK$1.17 B114.05%
2012HK$0.54 B288.58%
2011HK$0.14 B-62.57%
2010HK$0.37 B2.54%
2009HK$0.36 B224.37%
2008HK$0.11 B-58.22%
2007HK$0.27 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Arbutus Biopharma was reported to be:

HK$5.82 Billion
by Nasdaq info icon info icon
HK$5.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Nymox Pharmaceutical
NYMX
HK$0.14 B-97.55% Bahamas
NRC Health
NRC
HK$2.70 B-53.64%๐Ÿ‡บ๐Ÿ‡ธ USA